Yiqing Xu is an Oncology physician. OpenAlex indexes 89 publications with 1,270 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6300 8th Ave
Brooklyn, NY 112204718
Telephone
718-765-2600Registry record last updated 8 Jul 2007.
Industry payments
39 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SpringWorks Therapeutics, Inc.Program year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year202514 payments
- Daiichi Sankyo Inc.Program year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
48.1%Aromatase Inhibitor28.5%Anastrozole69%Letrozole27%Exemestane4%Part D<11 patientsKinase inhibitor13.4%Tagrisso45%Imatinib Mesylate18%Lenvima15%Lorbrena8%Everolimus8%Jakafi7%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
20.3%Serotonin-3 Receptor Antagonist5.6%Ondansetron Odt60%Ondansetron Hcl40%Part D≥30 patientsPotassium supplement5.4%Potassium Chloride100%Part D≥34 patients+ 7 more classes in this area
Nervous system
12.3%Gabapentinoids7.9%Gabapentin100%Part D≥27 patientsPhenothiazine4.4%Prochlorperazine Maleate100%Part D≥40 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”